Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 26;58(2):2100996.
doi: 10.1183/13993003.00996-2021. Print 2021 Aug.

Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation

Affiliations

Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation

Ingunn Skjørten et al. Eur Respir J. .

Abstract

Background: This study aimed to describe cardiopulmonary function during exercise 3 months after hospital discharge for COVID-19 and compare groups according to dyspnoea and intensive care unit (ICU) stay.

Methods: Participants with COVID-19 discharged from five large Norwegian hospitals were consecutively invited to a multicentre, prospective cohort study. In total, 156 participants (mean age 56.2 years, 60 females) were examined with a cardiopulmonary exercise test (CPET) 3 months after discharge and compared with a reference population. Dyspnoea was assessed using the modified Medical Research Council (mMRC) dyspnoea scale.

Results: Peak oxygen uptake (V'O2 peak) <80% predicted was observed in 31% (n=49). Ventilatory efficiency was reduced in 15% (n=24), while breathing reserve <15% was observed in 16% (n=25). Oxygen pulse <80% predicted was found in 18% (n=28). Dyspnoea (mMRC ≥1) was reported by 47% (n=59). These participants had similar V'O2 peak (p=0.10) but lower mean±sd V'O2 peak·kg-1 % predicted compared with participants without dyspnoea (mMRC 0) (76±16% versus 89±18%; p=0.009) due to higher body mass index (p=0.03). For ICU- versus non-ICU-treated participants, mean±sd V'O2 peak % predicted was 82±15% and 90±17% (p=0.004), respectively. Ventilation, breathing reserve and ventilatory efficiency were similar between the ICU and non-ICU groups.

Conclusions: One-third of participants experienced V'O2 peak <80% predicted 3 months after hospital discharge for COVID-19. Dyspnoeic participants were characterised by lower exercise capacity due to obesity and lower ventilatory efficiency. Ventilation and ventilatory efficiency were similar between ICU- and non-ICU-treated participants.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: I. Skjørten has provided lectures for doctors’ education paid by Norwegian Directorate of Health and Norwegian Medical Association. Conflict of interest: O.A.W. Ankerstjerne has nothing to disclose. Conflict of interest: D. Trebinjac has nothing to disclose. Conflict of interest: E. Brønstad has nothing to disclose. Conflict of interest: Ø. Rasch-Halvorsen has nothing to disclose. Conflict of interest: G. Einvik has received research grants from AstraZeneca and from Boehringer Ingelheim to perform the current study. Conflict of interest: T.V. Lerum has nothing to disclose. Conflict of interest: K. Stavem has nothing to disclose. Conflict of interest: A. Edvardsen is leader of the Norwegian Society for Clinical Physiology (unpaid), and has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from GlaxoSmithKline and Chiesi. Conflict of interest: C.B. Ingul has received lecture fees from Bayer AS, unrelated to the current study.

Figures

FIGURE 1
FIGURE 1
Patient flowchart. CPET: cardiopulmonary exercise test; CVD: cardiovascular disease; CHD: coronary heart disease: COPD: chronic obstructive pulmonary disease.

Comment in

References

    1. Zhou P, Yang XL, Wang XG, et al. . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270–273. doi:10.1038/s41586-020-2012-7 - DOI - PMC - PubMed
    1. Wiersinga WJ, Rhodes A, Cheng AC, et al. . Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 2020; 324: 782–793. doi:10.1001/jama.2020.12839 - DOI - PubMed
    1. Raman B, Cassar MP, Tunnicliffe EM, et al. . Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 2021; 31: 100683. doi:10.1016/j.eclinm.2020.100683 - DOI - PMC - PubMed
    1. Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397: 220–232. doi:10.1016/S0140-6736(20)32656-8 - DOI - PMC - PubMed
    1. Carfi A, Bernabei R, Landi F, et al. . Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324: 603–605. doi:10.1001/jama.2020.12603 - DOI - PMC - PubMed

Publication types